Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial

Multiple sclerosis (MS) is a possible cause of secondary osteoporosis. In this phase II trial we assessed whether a weekly dose of 20,000 IU vitamin D(3) prevents bone loss in ambulatory persons with MS age 18–50 years. ClinicalTrials.gov ID NCT00785473. All patients managed at the University Hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffensen, Linn H., Jørgensen, Lone, Straume, Bjørn, Mellgren, Svein Ivar, Kampman, Margitta T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165120/
https://www.ncbi.nlm.nih.gov/pubmed/21400196
http://dx.doi.org/10.1007/s00415-011-5980-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165120/
https://www.ncbi.nlm.nih.gov/pubmed/21400196
http://dx.doi.org/10.1007/s00415-011-5980-6

Ejemplares similares